Laboratorios Ojer Pharma, S.L. 

New Technologies for a New Skin. An evolution in Topical Dosage-Forms.


Carlos González (See Profile)


Drug Delivery


Sales, licensing phases



The technology has been applied to 4 of the most important dermatological APIs and protected by international patents

The Company has overcome the initial R&D stages and is getting different authorizations and certifications in Europe

Ojer has already reached license and development agreements in the main European markets, Korea, Canada and Mexico

This information is confidential, do not share or copy.

Under evaluation at least till: 26th March

If you want to have more information or you want to review the project, you have to login or register


©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

Aviso de cookies

Log in with your credentials


Forgot your details?

Create Account

Skip to toolbar